Nvidia, Unilever, Anglo American, JD Sports, ATOME - what brokers said today

Bank of America reiterated its 'Buy' rating and $190 price objective for NVIDIA Corp (NASDAQ:NVDA, ETR:NVD), citing the company’s dominant position in AI infrastructure despite delivering fourth-quarter guidance that fell short of bullish investor expectations.

While fiscal third-quarter results were solid, Nvidia’s Q4 revenue forecast of $37.5 billion, slightly above consensus, disappointed those anticipating closer to $40 billion.

Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) has earned a repeat ‘Outperform’ rating from Noble Capital analysts who see the company poised to build on a successful 2024 in the new year.

They see the stock surging more than 1,100% from its share price at the time of writing of $0.19 to $2.35.

Unilever PLC (LSE:ULVR) could confirm on Friday that it will spin out its ice cream arm via an initial public offer.

The owner of Cornetto and Ben & Jerry's is holding an investor day on November 22 in London, where the group's CEO and CFO will deliver presentations to major investors and analysts, along with the bosses of its global business units - with the "notable exception" of Ice Cream, analysts at UBS noted.

UBS has raised its price target for Anglo American PLC (LSE:AAL) to 2,800p from 2,700p, citing the company's imminent restructuring plans.

Analysts highlighted key developments expected in the next three months, including the sale of Anglo’s metallurgical coal assets and the planned spin-out of its Anglo American Platinum (Amplats) division.

Jefferies, the US investment bank, has raised to 530p its price target for AJ Bell PLC (LSE:AJB), which it notes is the only UK-quoted wealth management platform since the take-private of rival Hargreaves Lansdown.

This marks a 16% potential increase from the current share price of 457p.

Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF)’s proposed $10 million equity agreement with AOP Health International Management “should provide some much-needed breathing room” for the AIM-listed pharma group, said Stifel analysts.

“This, along with the business looking to lower its cost base by circa 10%, will help strengthen the balance sheet and support achieving cash flow breakeven by 2025 year-end,” they stated, adding that the company is “on track for 2024”.

JD Sports Fashion PLC (LSE:JD.) spooked investors after warning full-year profit would be at the low end of expectations due to “volatile” trading over the third quarter.

Consumer caution, unseasonal weather and the US election were all cited as having hit trading in October, leaving pre-tax profit on course to sit closer to £955 million in its range of up to £1,035 million.

Shares in specialist lender Close Brothers Group PLC (LSE:CBG) are extremely cheap at the moment, but analysts warn that investors hoping for a quick dose of alpha could be waiting a while.

On a tangible book value (TBV) to price basis (which is a key valuation ratio in finance), Close Bros shares are trading in the ballpark of just 0.2% times, per KBW analysis.

Shares in Ithaca Energy PLC (LSE:ITH) rose 7% in early trading after the company announced a £158 million special dividend following its merger with Italy's Eni and a refinancing deal.

The dividend keeps pace with Ithaca's target of £400 million ($500 million) returns to shareholders pledged in 2023.

Shares of Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) surged 27% in early trading after strong October sales of its iron deficiency drug ACCRUFeR, driven by an increase in net selling price to over $225 per prescription from $167 in the prior quarter.

This growth keeps the company on track to achieve its 2024 revenue target of $31.5 million, a key requirement under its debt agreement with SWK Funding.

Shares of ATOME PLC (AIM:ATOM) were up 7% in early trading after IDB Invest, the investment arm of the Inter-American Development Bank, released a consultation on $200 million debt funding for the company’s Villeta Project in Paraguay.

The proposed funding, an increase from earlier discussions, follows the successful completion of environmental and social impact studies, a crucial milestone for the project.

The share price didn't reflect this, but NVIDIA Corp's (NASDAQ:NVDA, ETR:NVD) third-quarter results ticked a lot of the boxes that had been unfilled ahead of the release of the numbers, according to Wedbush Securities, the tech-focused investment bank.

Nvidia's numbers met heightened investor expectations, with the AI chipmaker reporting $35 billion in revenue, fuelled by robust data centre sales and a ramp-up of its H200 chips.